Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Annovis Bio ( (ANVS) ) has provided an announcement.
Annovis Bio, Inc. has appointed William Fricker as interim Chief Financial Officer, bringing extensive experience from his previous roles in biotech and pharmaceutical companies. His expertise includes taking NRX Pharmaceuticals public and serving key financial roles at Immunomedics, Bristol Myers Squibb, and Johnson & Johnson. Fricker’s appointment is expected to strengthen Annovis’ financial strategies and operations.
For an in-depth examination of ANVS stock, go to TipRanks’ Stock Analysis page.
